Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More


Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Build It or Buy It: Novel Assays to Identify and Characterize Tuberculosis

Expanding spoligotyping of multidrug-resistant tuberculosis to the Luminex xMAP® platform to increase reproducibility, flexibility and throughput

Approximately one third of the world’s population is infected with the tuberculosis (TB) bacteria, Mycobacterium tuberculosis Complex (MTBC), which is one of the deadliest infectious diseases world-wide. One of the greatest threats to global TB control is the growing prevalence of drug resistant strains…”

Continue Reading…

ARIES® System &
SYNCT™ Software

Experience an ARIES® System & SYNCT™ Software, enabling cassettes to be associated with orders from anywhere in the lab network.

Watch more videos >

Luminex on Twitter

Something went wrong with the twitter.

Latest News

August 8
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

August 3
Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus

July 28
Luminex Corporation Reports Second Quarter 2016 Results

July 20
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

July 8
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016

July 6
Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System


34th Annual Conference on Pediatric Infectious Diseases
July 31-August 5
Vail, CO

AACC Annual Meeting & Clinical Lab Expo
August 2-4
Philadelphia, PA

SWACM Annual Meeting
September 7-10
Ft. Worth, TX

October 26-30
New Orleans, LA

AMP Annual Meeting
November 10-12
Charlotte, NC